Synthesis and structure -: Activity relationship studies of 3,6-diazabicyclo[3.2.0]heptanes as novel α4β2 nicotinic acetylcholine receptor selective Agonists

被引:37
|
作者
Ji, Jianguo
Schrimpf, Michael R.
Sippy, Kevin B.
Bunnelle, William H.
Li, Tao
Anderson, David J.
Faltynek, Connie
Surowy, Carol S.
Dyhring, Tino
Ahring, Philip K.
Meyer, Michael D.
机构
[1] Nuerosci Res, Abbott Pk, IL 60064 USA
[2] NeuroSearch A S, Ballerup, Denmark
关键词
D O I
10.1021/jm070755h
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A series of novel, potent neuronal nicotinic acetylcholine receptor (nAChR) ligands derived from 3,6-diazabicyclo[3.2.0]heptane have been synthesized and evaluated for binding affinity and agonist activity at the alpha 4 beta 2 nAChR subtype. Structure- activity relationship studies of these novel nAChR ligands focused on substitution effects on the pyridine ring, as well as stereo- and regiochemical influences of the 3,6-diazabicyclo[3.2.0]heptane core. Small 5-substituents on the pyridine ring had a modest impact on the binding affinities and functional activities. 6-Bromo, 6-chloro, and 6-methyl substituents on the pyridine ring led to increased binding affinities and improved functional activities. Most of the 6-N-pyridinyl -substituted 3,6-diazabicyclo[3.2.0]heptanes are selective for the alpha A beta 2 nAChR subtype. Compounds (IR,5S)-25, (I R,5S)55, and (I R,5S)-56 were virtually inactive as agonists at the h alpha 3 beta 4 nAChR but retained potency and efficacy at the h alpha 4 beta 2 nAChR subtype. 3-N-Pyridinyl-substituted series demonstrated more complex SAR. (IR,5R)39, (1R,5R)-41, and (IR,5R)-42 were found to be much more potent at the h alpha 3 beta 4.nAChR subtype, whereas (IR,5R)-38 and (JR,5R)-40 were very selective at the h alpha 4 beta 2 nAChR subtype. The SAR studies of these novel ligands led to the discovery of several compounds with interesting in vitro pharmacological profiles.
引用
收藏
页码:5493 / 5508
页数:16
相关论文
共 50 条
  • [31] Synthesis and Behavioral Studies of Chiral Cyclopropanes as Selective α4β2-Nicotinic Acetylcholine Receptor Partial Agonists Exhibiting an Antidepressant Profile. Part Ill
    Onajole, Oluseye K.
    Vallerini, Gian Paolo
    Eaton, J. Brek
    Lukas, Ronald J.
    Brunner, Dani
    Caldarone, Barbara J.
    Kozikowski, Alan P.
    ACS CHEMICAL NEUROSCIENCE, 2016, 7 (06): : 811 - 822
  • [32] Design, Synthesis, and Structure-Activity Relationship Studies of Novel Indolyalkylpiperazine Derivatives as Selective 5-HT1A Receptor Agonists
    Wang, Wenli
    Zheng, Lan
    Li, Wei
    Zhu, Chen
    Peng, Weiqing
    Han, Bing
    Fu, Wei
    JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2020, 60 (01) : 235 - 248
  • [33] Discovery and Structure-Activity Relationship Studies of Novel Adenosine A1 Receptor-Selective Agonists
    Preti, Barbara
    Suchankova, Anna
    Deganutti, Giuseppe
    Leuenberger, Michele
    Barkan, Kerry
    Manulak, Iga
    Huang, Xianglin
    Carvalho, Sabrina
    Ladds, Graham
    Lochner, Martin
    JOURNAL OF MEDICINAL CHEMISTRY, 2022, 65 (21) : 14864 - 14890
  • [34] Pyridinyl- and pyridazinyl-3,6-diazabicyclo[3.1.1]heptane-anilines: Novel selective ligands with subnanomolar affinity for α4β2 nACh receptors
    Deligia, Francesco
    Murineddu, Gabriele
    Gotti, Cecilia
    Ragusa, Giulio
    Fasoli, Francesca
    Sciaccaluga, Miriam
    Plutino, Simona
    Fucile, Sergio
    Loriga, Giovanni
    Asproni, Battistina
    Pinna, Gerard A.
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2018, 152 : 401 - 416
  • [35] Structure-Function Studies of the α4β2 Nicotinic Acetylcholine Receptor in a Lipidic Environment
    Kang, Guipeun
    BIOPHYSICAL JOURNAL, 2020, 118 (03) : 211A - 211A
  • [36] Discovery of fused azetidines as novel selective α4β2 neuronal nicotinic receptor (NNR) agonists
    Ji, JG
    Bunnelle, WH
    Li, T
    Pace, JM
    Schrimpf, MR
    Sippy, KB
    Anderson, DJ
    Meyer, MD
    PURE AND APPLIED CHEMISTRY, 2005, 77 (12) : 2041 - 2045
  • [37] Design and Synthesis of α-Conotoxin GID Analogues as Selective α4β2 Nicotinic Acetylcholine Receptor Antagonists
    Banerjee, Jayati
    Yongye, Austin B.
    Chang, Yi-Pin
    Gyanda, Reena
    Medina-Franco, Jose L.
    Armishaw, Christopher J.
    BIOPOLYMERS, 2014, 102 (01) : 78 - 87
  • [38] Dual Nicotinic Acetylcholine Receptor α4β2 Antagonists/α7 Agonists: Synthesis, Docking Studies, and Pharmacological Evaluation of Tetrahydroisoquinolines and Tetrahydroisoquinolinium Salts
    Crestey, Francois
    Jensen, Anders A.
    Soerensen, Christian
    Magnus, Charlotte Busk
    Andreasen, Jesper T.
    Peters, Gunther H. J.
    Kristensen, Jesper L.
    JOURNAL OF MEDICINAL CHEMISTRY, 2018, 61 (04) : 1719 - 1729
  • [39] Chemistry and Behavioral Studies Identify Chiral Cyclopropanes as Selective α4β2-Nicotinic Acetylcholine Receptor Partial Agonists Exhibiting an Antidepressant Profile
    Zhang, Hankun
    Tueckmantel, Werner
    Eaton, J. Brek
    Yuen, Po-wai
    Yu, Li-Fang
    Bajjuri, Krishna Mohan
    Fedolak, Allison
    Wang, Daguang
    Ghavami, Afshin
    Caldarone, Barbara
    Paterson, Neil E.
    Lowe, David A.
    Brunner, Daniela
    Lukas, Ronald J.
    Kozikowski, Alan P.
    JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (02) : 717 - 724
  • [40] Toll-like Receptor 7 Selective Synthetic Oligoribonucleotide Agonists: Synthesis and Structure-Activity Relationship Studies
    Lan, Tao
    Dai, Meiru
    Wang, Daqing
    Zhu, Fu-Gang
    Kandimalla, Ekambar R.
    Agrawal, Sudhir
    JOURNAL OF MEDICINAL CHEMISTRY, 2009, 52 (21) : 6871 - 6879